Prosecution Insights
Prosecution Insights
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (17%) |
| §101 + other | 1 (17%) |
| §103 only | 3 (50%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LAGOY, KYRA RAND | 1 | 11.8% | -14.3% |
| HAMA, JOANNE | 1 | 25.1% | +38.8% |
| MONSHIPOURI, MARYAM | 1 | 79.0% | +37.3% |
| MCMILLIAN, KARA RENITA | 1 | 30.4% | +37.9% |
| JOHNSON, KARA D | 1 | 69.1% | +24.6% |
| BEANE, RANDALL L | 1 | 32.8% | +36.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18877477 | CLINICAL TRIAL ASSISTANCE METHOD AND CLINICAL TRIAL ASSISTANCE SYSTEM | LAGOY, KYRA RAND | 73d overdue |
| 18690047 | METHOD FOR DETECTING ALZHEIMER'S DISEASE, AND DETECTION REAGENT | MONSHIPOURI, MARYAM | 15d overdue |
| 18703972 | METHOD FOR DETECTING KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, METHOD FOR DETERMINING RENAL PROGNOSIS, DETECTION KIT FOR KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, AND KIDNEY DYSFUNCTION DIAGNOSTIC MARKER | HAMA, JOANNE | — |
| 18572244 | NOVEL THERAPEUTIC AGENT THAT SUPPRESSES METASTASIS AND PROLIFERATION OF OSTEOSARCOMA AND GLIOMA | MCMILLIAN, KARA RENITA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18239938 | PRIMARY CULTURE METHOD | JOHNSON, KARA D | 70d overdue |
| 18690047 | METHOD FOR DETECTING ALZHEIMER'S DISEASE, AND DETECTION REAGENT | MONSHIPOURI, MARYAM | 15d overdue |
| 18703972 | METHOD FOR DETECTING KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, METHOD FOR DETERMINING RENAL PROGNOSIS, DETECTION KIT FOR KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, AND KIDNEY DYSFUNCTION DIAGNOSTIC MARKER | HAMA, JOANNE | — |
| 18572244 | NOVEL THERAPEUTIC AGENT THAT SUPPRESSES METASTASIS AND PROLIFERATION OF OSTEOSARCOMA AND GLIOMA | MCMILLIAN, KARA RENITA | — |
| 18263947 | APPLICATION OF GILTERITINIB TO VARIOUS MUTANTS | BEANE, RANDALL L | — |
| Art Unit | Apps |
|---|---|
| 3685 | 1 |
| 1647 | 1 |
| 1651 | 1 |
| 1623 | 1 |
| 1632 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18877477 | CLINICAL TRIAL ASSISTANCE METHOD AND CLINICAL TRIAL ASSISTANCE SYSTEM | LAGOY, KYRA RAND | 3685 | §103 | Final Rejection | 73d overdue | Pending | Dec 20, 2024 |
| 18703972 | METHOD FOR DETECTING KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, METHOD FOR DETERMINING RENAL PROGNOSIS, DETECTION KIT FOR KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, AND KIDNEY DYSFUNCTION DIAGNOSTIC MARKER | HAMA, JOANNE | 1647 | §101§103 | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18690047 | METHOD FOR DETECTING ALZHEIMER'S DISEASE, AND DETECTION REAGENT | MONSHIPOURI, MARYAM | 1651 | §103§112 | Non-Final OA | 15d overdue | Pending | Mar 07, 2024 |
| 18572244 | NOVEL THERAPEUTIC AGENT THAT SUPPRESSES METASTASIS AND PROLIFERATION OF OSTEOSARCOMA AND GLIOMA | MCMILLIAN, KARA RENITA | 1623 | §101 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18239938 | PRIMARY CULTURE METHOD | JOHNSON, KARA D | 1632 | §103 | Final Rejection | 70d overdue | Pending | Aug 30, 2023 |
| 18263947 | APPLICATION OF GILTERITINIB TO VARIOUS MUTANTS | BEANE, RANDALL L | 1654 | §103 | Final Rejection | — | Pending | Aug 02, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial